SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000078003-22-000091
Filing Date
2022-07-28
Accepted
2022-07-28 08:09:00
Documents
15
Period of Report
2022-07-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pfe-20220728.htm   iXBRL 8-K 44997
2 EX-99 pfe-07032022xex99.htm EX-99 1585184
7 pfizerlogoa.jpg GRAPHIC 38679
  Complete submission text file 0000078003-22-000091.txt   1956531

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pfe-20220728.xsd EX-101.SCH 2733
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pfe-20220728_def.xml EX-101.DEF 15407
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pfe-20220728_lab.xml EX-101.LAB 30338
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pfe-20220728_pre.xml EX-101.PRE 16025
9 EXTRACTED XBRL INSTANCE DOCUMENT pfe-20220728_htm.xml XML 14249
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 221112886
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences